SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Henrohn Dan)
 

Search: WFRF:(Henrohn Dan) > Acute vasodilator r...

Acute vasodilator response to vardenafil and clinical outcome in patients with pulmonary hypertension

Sandqvist, Anna, 1980- (author)
Umeå universitet,Farmakologi,Umea Univ, Div Clin Pharmacol, Dept Pharmacol & Clin Neurosci, Umea, Sweden.
Henrohn, Dan (author)
Uppsala universitet,Institutionen för medicinska vetenskaper
Egeröd, Hanna (author)
Uppsala universitet,Institutionen för medicinska vetenskaper
show more...
Hedeland, Mikael (author)
Uppsala universitet,Avdelningen för analytisk farmaceutisk kemi,Natl Vet Inst SVA, Dept Chem, Uppsala, Sweden.
Wernroth, Lisa (author)
Uppsala universitet,Uppsala kliniska forskningscentrum (UCR)
Bondesson, Ulf (author)
Uppsala universitet,Avdelningen för analytisk farmaceutisk kemi,Natl Vet Inst SVA, Dept Chem, Uppsala, Sweden.
Schneede, Jörn (author)
Umeå universitet,Farmakologi,Umea Univ, Div Clin Pharmacol, Dept Pharmacol & Clin Neurosci, Umea, Sweden.
Wikström, Gerhard (author)
Uppsala universitet,Kardiologi
show less...
 (creator_code:org_t)
2015-08-05
2015
English.
In: European Journal of Clinical Pharmacology. - : Springer Science and Business Media LLC. - 0031-6970 .- 1432-1041. ; 71:10, s. 1165-1173
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • PURPOSE: Acute vasodilator testing is recommended in patients with pulmonary arterial hypertension to identify individuals who may benefit from long-term treatment with oral calcium channel blockers. The aim of this study was to investigate the use of vardenafil in acute vasoreactivity testing compared to adenosine.METHODS: A total of 20 patients eligible for right heart catheterisation were enrolled. Acute vasoreactivity testing was carried out with intravenous (iv) adenosine (n = 18) followed by oral vardenafil (n = 20). Haemodynamic responses were recorded at baseline and after 60 min (vardenafil). Responders were defined according to consensus guideline criteria.RESULTS: Both vardenafil and adenosine significantly decreased mean pulmonary arterial pressure (mPAP, p < 0.001 and p = 0.026, respectively) and pulmonary vascular resistance (p < 0.001 and p > 0.001, respectively), and significantly increased cardiac output (p = 0.001 and p = 0.005, respectively). Vardenafil reduced mPAP more than adenosine (p = 0.044), while adenosine resulted in higher responses of cardiac index (p = 0.009) and pulmonary arterial oxygen saturation (p = 0.042). Acute adverse reactions were common with adenosine, while no side effects were observed after a single oral dose vardenafil. Vardenafil identified five responders (out of 20), while adenosine identified three responders (out of 18). During a 7-year follow-up, vardenafil responders had significantly lower NT-proBNP levels compared to non-responders.CONCLUSIONS: Vardenafil may be safely used for acute vasoreactivity testing in patients with PH. A single oral dose of vardenafil is better tolerated than iv adenosine and may identify additional responders who could benefit from long-term vasodilator treatment.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)

Keyword

denosine
Vardenafil
Acute vasodilator test
Haemodynamics
Pulmonary hypertension
Right heart catheterisation
kardiologi
Cardiology

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view